This website uses cookies to enhance the user experience.
||
S

SERCA PHARMACEUTICALS AS921 663 846

Limited company
Gaustadalléen 21 0349 OSLO, Norge

SERCA PHARMACEUTICALS AS

Operating
Utvikle, markedsføre og selge medisinske produkter og utstyr, samt det som står i forbindelse med dette.
Utvikle legemidler.

Organization

Chairman of the board
Years since formation
7 years
since Nov 7, 2018
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
895,550
1 share class
Total number of shareholders
16
8 companies, 8 persons

Financials

Total operating income 2024
4,714,624
NOK
Annual total result 2024
-1,159,259
NOK
Total equity 2024
27,645,238
NOK
Last update: Sep 9, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
1.31 %
indirectly

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
U
UNIC REVISJON AS
Auditor-
S
STATEMENT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
5.43 %
indirectly
-
4.34 %
indirectly
-
3.28 %
indirectly
-
2.49 %
indirectly
-
2.14 %
indirectly
Managing Director/CEO
1.31 %
indirectly
-
1.31 %
indirectly
-
1.16 %
indirectly
-
1.16 %
indirectly
Last update: Jun 7, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
S
SARSIA SEED FOND II AS
Ordinary shares
362,247
40.45 %
I
INVEN2 AS
Ordinary shares
234,032
26.13 %
S
SATURN INVEST AS
Ordinary shares
97,632
10.9 %
M
MP PENSJON PK
Ordinary shares
81,438
9.09 %
H
HERSETH AS
Ordinary shares
40,000
4.47 %
K
K OG K AS
Ordinary shares
23,385
2.61 %
I
IFH CONSULTING AS
Ordinary shares
22,260
2.49 %
Ordinary shares
7,070
0.79 %
Ordinary shares
5,246
0.59 %
Ordinary shares
4,880
0.54 %
Ordinary shares
4,200
0.47 %
Ordinary shares
3,640
0.41 %
Ordinary shares
3,540
0.4 %
D
Ordinary shares
2,960
0.33 %
Ordinary shares
1,740
0.19 %
Ordinary shares
1,280
0.14 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
4,714,624
3,571,688
1,984,763
2,057,459
Annual Total Result
-1,159,259
-4,423,990
-2,795,714
-2,654,458
Total assets
40,622,026
17,923,659
12,568,622
17,275,207
Total liabilities
12,976,788
1,532,247
1,897,298
3,808,169
Total equity
27,645,238
16,391,412
10,671,324
13,467,038

P&L

Year2024202320222021
Total operating income
4,714,624
3,571,688
1,984,763
2,057,459
Total operating costs
6,241,130
7,992,931
4,734,155
4,720,256
Operating result
-1,526,506
-4,421,243
-2,749,392
-2,662,797
Financial income/costs
367,247
-2,747
-46,323
8,339
Profit before tax
-1,159,259
-4,423,990
-2,795,714
-2,654,458
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
-1,159,259
-4,423,990
-2,795,714
-2,654,458

Balance overview

Year2024202320222021
Total fixed assets
27,248,235
0
0
0
Total current assets
13,373,791
17,923,659
12,568,622
17,275,207
Total assets
40,622,026
17,923,659
12,568,622
17,275,207
Short term debt
4,362,021
1,532,247
1,897,298
3,808,169
Long term debt
8,614,767
0
0
0
Total liabilities
12,976,788
1,532,247
1,897,298
3,808,169
Contributed capital
20,815,402
20,815,402
10,671,324
13,467,038
Retained earnings
6,829,836
-4,423,990
0
0
Total equity
27,645,238
16,391,412
10,671,324
13,467,038
Total equity and liabilities
40,622,026
17,923,659
12,568,622
17,275,207

Classification

21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises